乳酸脱酶缺乏的癌细胞对Ym155诱导的DNA损伤的敏感性增加
bioRxiv : the preprint server for biology
|November 19, 2025
概括
患有SDHB缺乏症的遗传性叶红细胞瘤和偏角细胞瘤 (hPPGL) 患者表现出转移风险增加. 这项研究确定Ym155是一种强大的治疗剂,通过诱导DNA损伤,证明了对SDHB缺乏癌症的显著细胞毒性.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 线粒体生物学 线粒体生物学
背景情况:
- 遗传性色细胞瘤和偏角细胞瘤 (hPPGL) 综合征是由于 Succinate Dehydrogenase 基因 (SDHx) 的遗传突变引起的.
- 酸脱酶亚单元B (SDHB) 缺乏的瘤表现出高度的转移潜力,需要新的治疗策略.
- 目前对缺乏SDHB的癌症的治疗方法主要是息的,这凸显了改善治疗途径的迫切需要.
研究的目的:
- 发现新的SDH依赖的线粒体导向细胞毒剂,用于治疗SDHB缺乏的癌症.
- 调查线粒体离子体和化疗化合物对SDHB缺乏瘤细胞的潜力.
- 阐明SDHB缺乏细胞对特定化疗剂增强敏感性的机制.
主要方法:
- 使用了人类SDHB缺乏的UOK269 RCC细胞 (SDHB-KO) 和同源的SDHB重建的对照细胞 (SDHB-WT).
- 选了线粒体离子体 (2,4-Dinitrophenol,BAM15,Niclosamide,Nitazoxanide) 和化疗药物Ym155的优先细胞毒性.
- 在初级人体乳染色体细胞,小鼠乳染色体细胞和使用3 - 尼托普罗酸 (3-NPA) 建模SDH缺乏症的验证结果.
主要成果:
- 线粒体离子体对SDHB-KO细胞表现出偏好的细胞毒性.
- Ym155对SDHB-KO细胞表现出强烈的,五倍偏好的细胞毒性,在多种细胞类型和模型中得到验证.
- 诱导Ym155的细胞毒性与SDH缺陷中介的DNA损伤,受损的DNA修复和增强的ROS生成有关,独立于Survivin.
结论:
- SDH缺陷使人对Ym155产生独特的敏感性,这种敏感性是由受损的DNA修复和增加的ROS生成所介导的.
- 在SDH缺乏的瘤中,酸盐的积累抑制了KDM4的活性,导致DNA修复缺陷和Ym155敏感性.
- 这些发现揭示了SDHB缺乏癌症的内在易感性,可以在治疗上发挥作用.
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Mutations
42.6K
Mutations are changes in the sequence of DNA. These changes can occur spontaneously or they can be induced by exposure to environmental factors. Mutations can be characterized in a number of different ways: whether and how they alter the amino acid sequence of the protein, whether they occur over a small or large area of DNA, and whether they occur in somatic cells or germline cells.
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
42.6K
Electron Transport Chain: Complex I and II
18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
DNA Damage can Stall the Cell Cycle
9.9K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.9K
DNA Damage Can Stall the Cell Cycle
3.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
3.0K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K


